SLS
$SLS
SELLAS Life Sciences Group, Inc.
Biotech company developing cancer immunotherapies.
Healthcare$4.93
-0.02 (-0.40%)
Day Range$4.88 - $5.03
Prev Close$4.95
Analyst Rating
Strong Buy
5 Buy / 1 Hold / 0 Sell
Subscribers
1
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
SLS: Pipeline Momentum vs Execution Risk
Sellas Life Sciences ($SLS) has seen momentum from AML preclinical data and a Q4 beat, yet negative earnings, high volatility and execution risk keep the case balanced. Upcoming Q1 results and clinical readouts will be key.
Apr 5, 2026